Early Detection of Adverse Drug Events via 24-h Telephone Services in a Community Pharmacy: A Case Report.

A 57-year-old woman with bipolar disorder (BD) was started on combination therapy with aripiprazole and lithium. At the same time, a community pharmacist administered follow-up through 24-h telephone services for the early detection of adverse events. Four days after starting therapy, the patient called a community pharmacy after working hours and mentioned the occurrence of disabilities, possibly due to adverse effects, including extrapyramidal symptoms (EPSs), to the pharmacist who received the forwarded call.

Utilizing questionnaires for medication counselling of patients taking antipsychotics during the COVID-19 pandemic: a single site, community pharmacy-based survey study.

Background: During the coronavirus disease (COVID-19) pandemic, general strategies for preventing infectious diseases, such as social distancing and the use of protective equipment have resulted in communication barriers between pharmacists and patients in community pharmacies.

Methods: To resolve these communication challenges to medication counselling during the COVID-19 pandemic, during their waiting time at our community pharmacy, we administered two questionnaires to patients receiving at least one antipsychotic drug. The first questionnaire, Questionnaire (A), included questions about any problems with wearing a mask and face shield, forgetting to take medication and adverse effects of their medication.

A community pharmacist's intervention in antipsychotic drug-induced sexual dysfunction in a patient with schizophrenia.

The community pharmacist interviewed a patient with sexual dysfunction (SD) and suggested a change in prescription. Early intervention by the community pharmacist ameliorated antipsychotic drug-induced SD timeously.